Subscribe for the latest consumer trends, trade news, nutrition science and regulatory updates in the supplement industry!
Join 37,000+ members. Yes, it's completely free.
March 1, 2000
1 Min Read
LPJ Issued Patent
SEYMOUR, Ill.--LPJ Research Inc. announced it has been issued a patent forits prohormone 19-Nor-4-Androstenediol. The patent, number 6,011,027, wasgranted on the basis that 19-Nor-4-Androstenediol increases 19-nortestosteronelevels in humans. 19-Nor-4-Androstenediol is a close chemical derivative oftestosterone, which is known for its ability to increase lean muscle and bonemass, improve sexual function and promote psychological well being, according toLPJ. For more information, contact LPJ at (217) 687-4138.
You May Also Like